Kuickresearch::Industry News

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

FDA grants orphan drug designation to Nintedanib for Systemic Sclerosis

Release Date: 03 October 2016

Boehringer Ingelheim’s nintedanib has been approved as orphan drug for the treatment of systemic sclerosis (SSc), also called scleroderma. FDA has taken an inevitable step forward in prevention and cure of Scleroderma, including as...

Read More


Cancer Immunotherapy Pipeline Has 1834 Drugs In Clinical Trials

Release Date: 07 October 2015

Cancer incidences are escalating rapidly across the globe and investigators are looking for modalities with superior pharmaceutical benefits. Immune system could be trained to identify and eliminate particular cells from...

Read More


Personalized Cancer Vaccines to Transform Oncology Market Landscape

Release Date: 21 November 2014

In the last decade, many significant technological advances have been made in the field of personalized cancer vaccine. In addition to the injections, implanted cancer vaccine technology has been use for better delivery ...

Read More


Orphan Drugs Show Potential With 600 Drugs in Pipeline

Release Date: 22 September 2014

Global Orphan Drug Market Report Findings:

Need custom market research solution? We can help you with that too.